Published in J Hepatol on June 10, 2009
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int (2015) 1.92
Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study. Med J Armed Forces India (2012) 1.44
Occult HBV infection. Semin Immunopathol (2012) 1.37
An overview of occult hepatitis B virus infection. World J Gastroenterol (2011) 1.32
Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities. Hepat Mon (2011) 0.97
Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol (2011) 0.97
Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J (2010) 0.97
The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection. Inflammation (2012) 0.96
A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med Microbiol Immunol (2012) 0.95
Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol (2011) 0.94
Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol (2013) 0.92
Occult hepatitis B virus infection. World J Hepatol (2014) 0.90
Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination. Blood Transfus (2013) 0.87
Occult hepatitis B virus infection: a complex entity with relevant clinical implications. World J Gastroenterol (2011) 0.86
Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat (2013) 0.84
Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon (2016) 0.84
The clinical significance of occult HBV infection. Ann Gastroenterol (2014) 0.83
Pre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity. Ann Lab Med (2011) 0.83
Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med (2011) 0.82
Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus (2013) 0.82
Occult hepatitis B virus infection and blood transfusion. World J Hepatol (2015) 0.81
Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus (2011) 0.81
Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Glob Health (2014) 0.81
Epidemiology of hepatitis B virus infection in first-time blood donors in the southwestern region of Goiás, central Brazil. Rev Bras Hematol Hemoter (2011) 0.81
Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil. Virol J (2014) 0.79
Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil. J Transfus (2011) 0.79
Molecular virology in transfusion medicine laboratory. Blood Transfus (2012) 0.79
Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy. Vox Sang (2014) 0.78
Occult hepatitis B virus infection among blood donors in Colombia. Virol J (2014) 0.78
Decrease in hepatitis B prevalence among blood donors in Central-West Brazil. J Venom Anim Toxins Incl Trop Dis (2013) 0.77
The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PLoS One (2013) 0.77
Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic. PLoS One (2015) 0.76
Update on occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75
The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City. Jundishapur J Microbiol (2016) 0.75
Hepatitis B transmission by cell and tissue allografts: how safe is safe enough? World J Gastroenterol (2014) 0.75
Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism. Proc Natl Acad Sci U S A (2016) 0.75
Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health (2016) 0.75
Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus (2016) 0.75
Quantification of Transfusion Recipients at Risk of Receiving Hepatitis B Virus-Contaminated Blood Components: A Korean Study. Indian J Hematol Blood Transfus (2015) 0.75
Testing for hepatitis B virus core antigen and e antigen may confer additional safety of donors' blood negative for heptitis B virus surface antigen. Asian J Transfus Sci (2014) 0.75
Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran. Electron Physician (2013) 0.75
Genetic variation of occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75
Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing. Transfus Med Hemother (2017) 0.75
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods (2004) 1.33
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol (2008) 1.25
Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol (2007) 1.23
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol (2007) 1.06
Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology (2006) 1.04
Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol (2005) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion (2009) 1.00
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population. J Med Virol (2007) 1.00
Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol (2011) 1.00
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol (2009) 0.98
External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med (2012) 0.98
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol (2008) 0.96
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis (2011) 0.95
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94
Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals (2010) 0.93
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol (2009) 0.93
Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol (2013) 0.92
The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion (2009) 0.92
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion (2012) 0.89
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol (2008) 0.89
Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine. Clin Vaccine Immunol (2007) 0.89
Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol (2009) 0.87
Nucleic acid dipstick test for molecular diagnosis of pandemic H1N1. J Clin Microbiol (2010) 0.87
Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors. Transfusion (2014) 0.86
Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS (2004) 0.86
Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo. PLoS One (2012) 0.86
Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol (2006) 0.85
Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion (2006) 0.85
Infection of common marmosets with hepatitis C virus/GB virus-B chimeras. Hepatology (2014) 0.84
Can family or replacement blood donors become regular volunteer donors? Transfusion (2013) 0.84
Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. PLoS One (2013) 0.83
Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion (2003) 0.83
Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity. J Clin Microbiol (2012) 0.82
Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion (2005) 0.82
Plasmodium genome in blood donors at risk for malaria after several years of residence in Italy. Transfusion (2014) 0.82
Malaria and transfusion: a neglected subject coming back to the forefront. Clin Infect Dis (2010) 0.81
Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol (2006) 0.81
Seroprevalence of west nile virus in ghana. Viral Immunol (2009) 0.80
Maternal-fetal transmission of human parvovirus B19 genotype 3. J Infect Dis (2006) 0.80
Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant. J Med Virol (2011) 0.80
Chimeric monoclonal antibodies to hypervariable region 1 of hepatitis C virus. J Gen Virol (2005) 0.80
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother. J Hepatol (2011) 0.80
GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals. AIDS (2006) 0.80
Risk assessment and cost-effectiveness/utility analysis. Biologicals (2009) 0.80
Occult hepatitis B virus infection and transfusion. J Hepatol (2005) 0.79
Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus. PLoS One (2013) 0.79
Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion (2013) 0.79
Molecular virology in transfusion medicine laboratory. Blood Transfus (2012) 0.79
This article has been retracted: Trends in the frequency of blood donors donating blood to be tested for HIV in Shiraz from 2004 to 2006. Transfus Med (2010) 0.78
Potential risk of blood transfusion-transmitted brucellosis in an endemic area of China. Transfusion (2014) 0.78
Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion (2012) 0.78
West Nile virus and blood donors. Lancet (2003) 0.78
Fourteen-year experience of a tertiary hospital transfusion committee in West Africa. Transfusion (2014) 0.78
Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR. Blood (2003) 0.77
Impact of host responses on control of hepatitis C virus infection in Chinese blood donors. Biochem Biophys Res Commun (2011) 0.77
Vertical transmission of HIV in Ghanaian women diagnosed in cord blood and post-natal samples. J Med Virol (2005) 0.77
Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J Virol (2005) 0.77
Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol (2013) 0.77
HIV safety in sub-Saharan Africa. Vox Sang (2010) 0.77
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage. Shock (2015) 0.76
Hepatitis B virus infection does not significantly influence Plasmodium parasite density in asymptomatic infections in Ghanaian transfusion recipients. PLoS One (2012) 0.76
Predonation testing of potential blood donors in resource-restricted settings. Transfusion (2005) 0.75
Estimation of HBV transfusion risk. Transfusion (2009) 0.75
Hepatitis C virus antibody confirmation in resource-poor settings. Transfusion (2008) 0.75
Occult Hepatitis B Virus Infection in Hyperlipidemia Patients. Tohoku J Exp Med (2017) 0.75
International Association for Biologicals Symposium: "Advances in Transfusion Safety", Cambridge, UK. Foreword. Biologicals (2009) 0.75
GB virus C genotype 1 is rarely transmitted vertically but acquired during infancy in West Africa. AIDS (2006) 0.75